Studies have shown that the incidence of elevated CA19-9 and CEA in patients with hepatic sarcomatoid carcinoma is significantly higher than that in HCC patients, while the incidence of elevated AFP is much lower than that in HCC,[1] which is helpful for the differential diagnosis of HSC and HCC. The gene discussed is AFP; the disease is hepatocellular carcinoma.